Increased plasma levels of endocan are thought to be a possible immuno-inflammatory marker that may represent endothelial activation and dysfunction and may be linked to diseases causing endothelial damage like diabetes [14, 57]. The gene discussed is ESM1; the disease is diabetes mellitus.